| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 299575
[patent_doc_number] => 07537773
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-26
[patent_title] => 'Chemodenervating pharmaceutical as anti-inflammatory agent'
[patent_app_type] => utility
[patent_app_number] => 09/382837
[patent_app_country] => US
[patent_app_date] => 1999-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 6155
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/537/07537773.pdf
[firstpage_image] =>[orig_patent_app_number] => 09382837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/382837 | Chemodenervating pharmaceutical as anti-inflammatory agent | Aug 24, 1999 | Issued |
| 09/382088 | COMPOSITIONS AND METHODS FOR PROTECTING ORGANS, TISSUE AND CELLS FROM IMMUNE SYSTEM-MEDIATED DAMAGE | Aug 23, 1999 | Abandoned |
| 09/377990 | SIALIDASES AS MUCOSAL ADJUVANTS | Aug 19, 1999 | Abandoned |
| 09/331205 | VACCINE PREPARATION FOR THE REVERSIBLE IMMUNOCASTRATION OF MAMMALS | Aug 12, 1999 | Abandoned |
Array
(
[id] => 4301480
[patent_doc_number] => 06187563
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => '.beta.IV-spectrin-polypeptides and nucleic acids encoding same'
[patent_app_type] => 1
[patent_app_number] => 9/368590
[patent_app_country] => US
[patent_app_date] => 1999-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 51
[patent_no_of_words] => 10275
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187563.pdf
[firstpage_image] =>[orig_patent_app_number] => 368590
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/368590 | .beta.IV-spectrin-polypeptides and nucleic acids encoding same | Aug 3, 1999 | Issued |
| 09/368069 | METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS | Aug 2, 1999 | Abandoned |
Array
(
[id] => 4254221
[patent_doc_number] => 06258357
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Inhibition of graft versus host disease'
[patent_app_type] => 1
[patent_app_number] => 9/363678
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4343
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258357.pdf
[firstpage_image] =>[orig_patent_app_number] => 363678
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/363678 | Inhibition of graft versus host disease | Jul 29, 1999 | Issued |
Array
(
[id] => 1253527
[patent_doc_number] => 06670337
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Facilitation of wound healing with CM101/GBS toxin'
[patent_app_type] => B1
[patent_app_number] => 09/363968
[patent_app_country] => US
[patent_app_date] => 1999-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5785
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670337.pdf
[firstpage_image] =>[orig_patent_app_number] => 09363968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/363968 | Facilitation of wound healing with CM101/GBS toxin | Jul 28, 1999 | Issued |
| 09/194327 | PRODRUGS OF THALIDOMIDE AND METHODS FOR USING SAME AS MODULATORS OF T-CELL FUNCTION | Jul 18, 1999 | Abandoned |
Array
(
[id] => 6876867
[patent_doc_number] => 20010007020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'ANTIBODIES THAT BIND TO THE NIDOGEN-BINDING DOMAIN OF LAMININ, THEIR PRODUCTION AND USE'
[patent_app_type] => new-utility
[patent_app_number] => 09/341643
[patent_app_country] => US
[patent_app_date] => 1999-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8548
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007020.pdf
[firstpage_image] =>[orig_patent_app_number] => 09341643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341643 | ANTIBODIES THAT BIND TO THE NIDOGEN-BINDING DOMAIN OF LAMININ, THEIR PRODUCTION AND USE | Jul 14, 1999 | Abandoned |
Array
(
[id] => 6242173
[patent_doc_number] => 20020045208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF THE MISTLETOE VISCUM ALBUM'
[patent_app_type] => new
[patent_app_number] => 09/347064
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23931
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045208.pdf
[firstpage_image] =>[orig_patent_app_number] => 09347064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/347064 | RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF THE MISTLETOE VISCUM ALBUM | Jul 1, 1999 | Abandoned |
Array
(
[id] => 4153919
[patent_doc_number] => 06114129
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Methods of detecting T-cell activation and treating disorders associated with T-cell dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/339944
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10996
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114129.pdf
[firstpage_image] =>[orig_patent_app_number] => 339944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339944 | Methods of detecting T-cell activation and treating disorders associated with T-cell dysfunction | Jun 24, 1999 | Issued |
Array
(
[id] => 4210175
[patent_doc_number] => 06086898
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Method of converting a Th2-type allergic immune response into a Th1-type immune response'
[patent_app_type] => 1
[patent_app_number] => 9/339068
[patent_app_country] => US
[patent_app_date] => 1999-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 15681
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/086/06086898.pdf
[firstpage_image] =>[orig_patent_app_number] => 339068
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339068 | Method of converting a Th2-type allergic immune response into a Th1-type immune response | Jun 22, 1999 | Issued |
Array
(
[id] => 990907
[patent_doc_number] => 06919434
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-19
[patent_title] => 'Monoclonal antibodies that bind OCIF'
[patent_app_type] => utility
[patent_app_number] => 09/338063
[patent_app_country] => US
[patent_app_date] => 1999-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 21335
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919434.pdf
[firstpage_image] =>[orig_patent_app_number] => 09338063
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/338063 | Monoclonal antibodies that bind OCIF | Jun 22, 1999 | Issued |
| 09/337746 | TRANSCUTANEOUS IMMUNIZATION OR IMMUNOSTIMULATION | Jun 21, 1999 | Abandoned |
| 09/335087 | SOLUBLE T CELL RECEPTOR | Jun 16, 1999 | Abandoned |
| 09/230392 | SIMPLIFIED PRODUCTION OF BISPECIFIC ANTIBODY FRAGMENTS | Jun 7, 1999 | Abandoned |
| 09/269482 | METHOD AND COMPOSITIONS FOR TREATMENT OF INSULIN-DEPENDANT DIABETES MELLITUS | Jun 6, 1999 | Abandoned |
Array
(
[id] => 1160374
[patent_doc_number] => 06759037
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Compositions and methods for treating diabetes'
[patent_app_type] => B1
[patent_app_number] => 09/323738
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 0
[patent_no_of_words] => 22575
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759037.pdf
[firstpage_image] =>[orig_patent_app_number] => 09323738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/323738 | Compositions and methods for treating diabetes | May 31, 1999 | Issued |
Array
(
[id] => 6032102
[patent_doc_number] => 20020018787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING IMMUNE RESPONSE AND FOR THE TREATMENT OF INFLAMMATORY DISEASE'
[patent_app_type] => new
[patent_app_number] => 09/316001
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4358
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018787.pdf
[firstpage_image] =>[orig_patent_app_number] => 09316001
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316001 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE RESPONSE AND FOR THE TREATMENT OF INFLAMMATORY DISEASE | May 20, 1999 | Abandoned |
